Pregnancy brings a flood of decisions, and genetic testing is one of the most significant. The options have expanded dramatically in recent years — and so has the confusion about what each test actually does, when it matters, and what it might cost you. Here's a clear breakdown of the landscape.
Before anything else, you need to understand this divide — because the two categories are fundamentally different in purpose and in what they tell you.
Screening tests assess probability. They estimate whether your pregnancy has an elevated risk for certain chromosomal conditions or structural abnormalities. They are non-invasive, carry no risk to the pregnancy, and are typically offered to all pregnant people. A screen result — positive or negative — does not confirm a diagnosis.
Diagnostic tests assess presence. They can confirm or rule out a specific chromosomal or genetic condition with much greater certainty. They require sampling fetal or placental cells, which makes them invasive and carries a small but real risk of pregnancy complications.
Which path you take — and whether you combine both — depends on your age, personal or family history, screening results, and what information would actually matter to your decision-making.
This typically combines two components:
NIPT is highly accurate for the most common chromosomal conditions in typical pregnancies, but its positive predictive value varies depending on the prevalence of the condition in the population being tested. A positive NIPT result generally warrants diagnostic follow-up before any major decisions are made.
| Test | How It Works | Timing | What It Can Confirm |
|---|---|---|---|
| Chorionic Villus Sampling (CVS) | Sample of placental tissue via needle or catheter | Weeks 10–13 | Chromosomal conditions, some genetic disorders |
| Amniocentesis | Sample of amniotic fluid via needle | Weeks 15–20+ | Chromosomal conditions, neural tube defects, some inherited disorders |
Both tests can be used for chromosomal microarray analysis or whole exome sequencing if specific genetic conditions are suspected. The miscarriage risk associated with each procedure is generally low but real, and varies by provider experience and clinical setting.
Diagnostic testing is typically offered when:
Carrier screening is different from the tests above — it looks at the parents, not the fetus, to assess whether they carry genetic variants associated with inherited conditions like cystic fibrosis, spinal muscular atrophy, sickle cell disease, or fragile X syndrome.
Carrier screening can be done before conception or early in pregnancy. If both partners carry a variant for the same recessive condition, there's an increased probability the child could be affected. This information may lead to diagnostic testing of the fetus or inform family planning decisions.
Cost varies widely and depends on several intersecting factors:
Factors that affect what you pay:
General cost ranges (without insurance):
These are general ranges — not guarantees. Always verify your actual costs with your provider and insurer before testing.
No single testing path fits everyone. Before deciding what testing makes sense, consider:
Genetic testing during pregnancy is not a single decision — it's a series of choices, each shaped by what stage of pregnancy you're in, what you want to know, and what your specific circumstances suggest. Understanding the types of tests available is the first step toward asking the right questions with your care team.
